Home › Funds › Carmignac Gestion › ALGN
Carmignac Gestion position in ALGN
ALIGN TECHNOLOGY INC · Health Care
Carmignac Gestion reported holding 372,232 shares of ALGN (ALIGN TECHNOLOGY INC) in its Q3 2026 13F filing — a position valued at US$54.1M, representing 0.86% of its reported portfolio and ranking #31 among its reported holdings. Carmignac Gestion has disclosed ALGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Carmignac Gestion's ALGN position evolved
Carmignac Gestion first disclosed a stake in ALGN in Q3 2023 at 12,802 shares (US$3.9M). The position peaked in Q3 2026 at 372,232 shares, worth US$54.1M. Across 13 filings, Carmignac Gestion increased the stake 10 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 372,232 shares valued at US$54.1M — an increase of 55,400 shares quarter over quarter.. Notable position changes include a 70% increase in Q1 2024 (shares fell 26% over the following quarter), a 68% increase in Q4 2024 (shares fell 24% over the following quarter), a 363% increase in Q3 2025 (shares rose 25% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 12.80K | $3.91M | New |
| Q4 2023 | 14.87K | $4.08M | Add |
| Q1 2024 | 25.30K | $8.30M | Add |
| Q2 2024 | 31.37K | $7.58M | Add |
| Q3 2024 | 31.57K | $8.03M | Add |
| Q4 2024 | 52.97K | $11.03M | Add |
| Q1 2025 | 56.77K | $9.02M | Add |
| Q2 2025 | 52.45K | $9.92M | Reduce |
| Q3 2025 | 242.91K | $30.43M | Add |
| Q4 2025 | 246.10K | $38.45M | Add |
| Q1 2026 | 225.17K | $38.54M | Reduce |
| Q2 2026 | 316.83K | $53.50M | Add |
| Q3 2026 | 372.23K | $54.09M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALGN and 13F data
ALGN (ALIGN TECHNOLOGY INC) is a Health Care company. 19 other funds we track also report a position in ALGN — the largest reported positions include Ninety One UK Ltd (US$310.1M), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$292.4M), Ruane Cunniff & Goldfarb (Sequoia) (US$197.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALGN
- Ninety One UK Ltd 2.13M sh · $310.12M · Q3 2026
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1.73M sh · $292.37M · Q2 2026
- Ruane Cunniff & Goldfarb (Sequoia) 1.17M sh · $197.58M · Q2 2026
- JACOBS LEVY EQUITY MANAGEMENT, INC 1.07M sh · $180.29M · Q2 2026
More on Carmignac Gestion
FAQ
How long has Carmignac Gestion held ALGN?
Carmignac Gestion has disclosed ALGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Carmignac Gestion's current position in ALGN?
As of Q3 2026, Carmignac Gestion holds 372.23K shares of ALGN (ALIGN TECHNOLOGY INC), valued at $54.09M, representing 0.86% of its reported portfolio and ranking #31.
Has Carmignac Gestion been buying or selling ALGN?
In the latest 13F filing (Q3 2026), Carmignac Gestion increased its position in ALGN. The position peaked in Q3 2026 at 372.23K shares.
Which other funds hold ALGN?
Other major institutional holders of ALGN include Ninety One UK Ltd, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Ruane Cunniff & Goldfarb (Sequoia), among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.